Who
Edward J. Ludwig
Director
Company insider
Files Form 4 as: Director, Boston Scientific; Director, CVS Health; Director, Aetna Inc /pa/; Director, Xylem; Chairman, Becton, Dickinson and.
In numbers
- Trades disclosed
- 293
- Buys
- 14
- Sells
- 34
- Bought
- $2.2M
- Sold
- $94.3M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 23 Dec 2005
- Last trade
- 31 Jul 2026
- Last filed
- 3 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Jul 2026filed 3 Aug 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Bought | $227K5,000 at $45.48 | filing |
| 31 Jul 2026filed 3 Aug 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Bought | $227K5,000 at $45.48 | filing |
| 20 May 2026filed 21 May 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Bought | $203K3,580 at $56.68 | filing |
| 20 May 2026filed 21 May 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Bought | $203K3,580 at $56.68 | filing |
| 7 May 2026filed 11 May 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code A | —3,800 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code A | —3,800 at $0.00 | filing |
| 1 Aug 2025filed 4 Aug 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code G | —500 at $0.00 | filing |
| 25 Jul 2025filed 28 Jul 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Sold | $424K4,000 at $106.03 | filing |
| 29 May 2025filed 30 May 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Sold | $418K4,000 at $104.59 | filing |
| 8 May 2025filed 9 May 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code A | —2,081 at $0.00 | filing |
| 11 Feb 2025filed 12 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code G | —3,000 at $0.00 | filing |
| 11 Feb 2025filed 12 Feb 2025 | BSX Boston ScientificMedical Devices | SEC FORM 4 Sold | $1.3M12,000 at $105.48 | filing |
| 21 Nov 2024filed 22 Nov 2024 | BSX Boston ScientificMedical Devices | SEC FORM 4 Sold | $447K4,877 at $91.63 | filing |
| 9 May 2024filed 13 May 2024 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code A | —2,901 at $0.00 | filing |
| 2 May 2024filed 2 May 2024 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Bought | $54K1,000 at $53.88 | filing |
| 26 Apr 2024filed 29 Apr 2024 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | $171K9,818 at $17.37 | filing |
| 26 Apr 2024filed 29 Apr 2024 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | $171K9,818 at $17.37 | filing |
| 26 Apr 2024filed 29 Apr 2024 | BSX Boston ScientificMedical Devices | SEC FORM 4 Sold | $720K9,818 at $73.29 | filing |
| 13 Feb 2024filed 14 Feb 2024 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —7,000 at $0.00 | filing |
| 13 Feb 2024filed 14 Feb 2024 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | $122K7,000 at $17.37 | filing |
News
Boston Scientific Corporation $BSX Stock: Goelzer Investment Management Inc. Raises PositionBSX · dailypolitical.com · 17 Oct 2026Boston Scientific (NYSE:BSX) Upgraded at BarclaysBSX · dailypolitical.com · 10 Oct 2026Financial Contrast: Sysmex (OTCMKTS:SSMXY) and Boston Scientific (NYSE:BSX)BSX · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Edward J. Ludwig; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.